<!doctype html><!-- This site was created with Wowchemy. https://www.wowchemy.com --><!-- Last Published: 2023. május 26. --><html lang=hu><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 5.7.0 for Hugo"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=preload as=style href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap"><link rel=stylesheet href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media=print onload='this.media="all"'><link rel=stylesheet href=/css/vendor-bundle.min.16f785cdb553c8c4431db6775122af35.css media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/academicons@1.9.2/css/academicons.min.css integrity="sha512-KlJCpRsLf+KKu2VQa5vmRuClRFjxc5lXO03ixZt82HZUk41+1I0bD8KBSA0fY290ayMfWYI9udIqeOWSu1/uZg==" crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=/css/wowchemy.0f229d4b7ebad1917a9a357cba2effab.css><link rel=stylesheet href=/css/libs/chroma/github-light.min.css title=hl-light media=print onload='this.media="all"'><link rel=stylesheet href=/css/libs/chroma/dracula.min.css title=hl-dark media=print onload='this.media="all"' disabled><script async src="https://www.googletagmanager.com/gtag/js?id=G-YGBRWXZLM1"></script>
<script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments)}function trackOutboundLink(e,t){gtag("event","click",{event_category:"outbound",event_label:e,transport_type:"beacon",event_callback:function(){t!=="_blank"&&(document.location=e)}}),console.debug("Outbound link clicked: "+e)}function onClickCallback(e){if(e.target.tagName!=="A"||e.target.host===window.location.host)return;trackOutboundLink(e.target,e.target.getAttribute("target"))}gtag("js",new Date),gtag("config","G-YGBRWXZLM1",{}),gtag("set",{cookie_flags:"SameSite=None;Secure"}),document.addEventListener("click",onClickCallback,!1)</script><script>(function(e,t,n,s,o,i,a){e[n]=e[n]||function(){(e[n].q=e[n].q||[]).push(arguments)},i=t.createElement(s),i.async=1,i.src="https://www.clarity.ms/tag/"+o,a=t.getElementsByTagName(s)[0],a.parentNode.insertBefore(i,a)})(window,document,"clarity","script","h7uhlm8mdb")</script><meta name=author content="Ferenci Tamás"><meta name=description content="INTRODUCTION AND AIM: The aim was to study the patients' adherence to some evidence-based medication (statins, beta blockers, platelet and RAS inhibitors) after suffering a myocardial infarction, and its impact on the outcome. METHOD: Retrospective observational cohort study was carried out from the data of the Hungarian Myocardial Infarction Registry between January 1, 2013, and December 31, 2014. 14,843 patients were alive at the end of hospital treatment, from them, those who had no myocardial infarction or death until 180 days were followed for one year. The adherence was defined as the proportion of time from the index event to the endpoint (or censoring) covered with prescription fillings. The endpoint was defined as death or reinfarction. Information on filling prescriptions for statins, platelet aggregation inhibitors, beta blockers and ARB/ACEI-inhibitors were obtained. Multivariate regression was used to model adherence and survival time. RESULTS: Good adherence (>80%) to clopidogrel, statins, beta blockers, aspirin and ARB/ACEI was found in 64.9%, 54.4%, 36.5%, 31.7% and 64.0%, respectively. Patients treated with PCI during the index hospitalization had higher adherence to all medication (all p<0.01), except for beta-blocker (p = 0.484). Multivariate analysis confirmed that adherence to statins, to clopidogrel and ARB/ACEI-inhibitors was associated with 10.1% (p<0.0001), 10.4% (p = 0.0002) and 15.8% (p<0.0001) lower hazard of endpoint respectively for 25% points increase in adherence, controlling for age, sex, performing of PCI, 5 anamnestic data and date of index event. Adherence to aspirin and beta blockers was not significantly associated with the hazard. CONCLUSION: Higher adherence to some evidence-based medications was found to be associated with improved long term prognosis of the patients. Orv Hetil. 2017; 158(27): 1051-1057."><link rel=alternate hreflang=hu href=https://www.medstat.hu/publication/mtmt-3246377/><link rel=canonical href=https://www.medstat.hu/publication/mtmt-3246377/><link rel=manifest href=/manifest.webmanifest><link rel=icon type=image/png href=/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_32x32_fill_lanczos_center_3.png><link rel=apple-touch-icon type=image/png href=/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_180x180_fill_lanczos_center_3.png><meta name=theme-color content="#1565c0"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:image" content="https://www.medstat.hu/media/sharing.png"><meta property="og:site_name" content="Ferenci Tamás honlapja"><meta property="og:url" content="https://www.medstat.hu/publication/mtmt-3246377/"><meta property="og:title" content="Szívinfarktust túlélt betegek terápiahűsége a másodlagos megelőzés szempontjából fontos gyógyszeres kezelésekhez | Ferenci Tamás honlapja"><meta property="og:description" content="INTRODUCTION AND AIM: The aim was to study the patients' adherence to some evidence-based medication (statins, beta blockers, platelet and RAS inhibitors) after suffering a myocardial infarction, and its impact on the outcome. METHOD: Retrospective observational cohort study was carried out from the data of the Hungarian Myocardial Infarction Registry between January 1, 2013, and December 31, 2014. 14,843 patients were alive at the end of hospital treatment, from them, those who had no myocardial infarction or death until 180 days were followed for one year. The adherence was defined as the proportion of time from the index event to the endpoint (or censoring) covered with prescription fillings. The endpoint was defined as death or reinfarction. Information on filling prescriptions for statins, platelet aggregation inhibitors, beta blockers and ARB/ACEI-inhibitors were obtained. Multivariate regression was used to model adherence and survival time. RESULTS: Good adherence (>80%) to clopidogrel, statins, beta blockers, aspirin and ARB/ACEI was found in 64.9%, 54.4%, 36.5%, 31.7% and 64.0%, respectively. Patients treated with PCI during the index hospitalization had higher adherence to all medication (all p<0.01), except for beta-blocker (p = 0.484). Multivariate analysis confirmed that adherence to statins, to clopidogrel and ARB/ACEI-inhibitors was associated with 10.1% (p<0.0001), 10.4% (p = 0.0002) and 15.8% (p<0.0001) lower hazard of endpoint respectively for 25% points increase in adherence, controlling for age, sex, performing of PCI, 5 anamnestic data and date of index event. Adherence to aspirin and beta blockers was not significantly associated with the hazard. CONCLUSION: Higher adherence to some evidence-based medications was found to be associated with improved long term prognosis of the patients. Orv Hetil. 2017; 158(27): 1051-1057."><meta property="og:image" content="https://www.medstat.hu/media/sharing.png"><meta property="og:locale" content="hu"><meta property="article:published_time" content="2023-04-10T18:21:37+00:00"><meta property="article:modified_time" content="2023-04-10T20:21:38+02:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://www.medstat.hu/publication/mtmt-3246377/"},"headline":"Szívinfarktust túlélt betegek terápiahűsége a másodlagos megelőzés szempontjából fontos gyógyszeres kezelésekhez","datePublished":"2023-04-10T18:21:37Z","dateModified":"2023-04-10T20:21:38+02:00","author":{"@type":"Person","name":"András Jánosi"},"publisher":{"@type":"Organization","name":"Ferenci Tamás honlapja","logo":{"@type":"ImageObject","url":"https://www.medstat.hu/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_192x192_fill_lanczos_center_3.png"}},"description":"INTRODUCTION AND AIM: The aim was to study the patients' adherence to some evidence-based medication (statins, beta blockers, platelet and RAS inhibitors) after suffering a myocardial infarction, and its impact on the outcome. METHOD: Retrospective observational cohort study was carried out from the data of the Hungarian Myocardial Infarction Registry between January 1, 2013, and December 31, 2014. 14,843 patients were alive at the end of hospital treatment, from them, those who had no myocardial infarction or death until 180 days were followed for one year. The adherence was defined as the proportion of time from the index event to the endpoint (or censoring) covered with prescription fillings. The endpoint was defined as death or reinfarction. Information on filling prescriptions for statins, platelet aggregation inhibitors, beta blockers and ARB/ACEI-inhibitors were obtained. Multivariate regression was used to model adherence and survival time. RESULTS: Good adherence (\u003e80%) to clopidogrel, statins, beta blockers, aspirin and ARB/ACEI was found in 64.9%, 54.4%, 36.5%, 31.7% and 64.0%, respectively. Patients treated with PCI during the index hospitalization had higher adherence to all medication (all p\u003c0.01), except for beta-blocker (p = 0.484). Multivariate analysis confirmed that adherence to statins, to clopidogrel and ARB/ACEI-inhibitors was associated with 10.1% (p\u003c0.0001), 10.4% (p = 0.0002) and 15.8% (p\u003c0.0001) lower hazard of endpoint respectively for 25% points increase in adherence, controlling for age, sex, performing of PCI, 5 anamnestic data and date of index event. Adherence to aspirin and beta blockers was not significantly associated with the hazard. CONCLUSION: Higher adherence to some evidence-based medications was found to be associated with improved long term prognosis of the patients. Orv Hetil. 2017; 158(27): 1051-1057."}</script><title>Szívinfarktust túlélt betegek terápiahűsége a másodlagos megelőzés szempontjából fontos gyógyszeres kezelésekhez | Ferenci Tamás honlapja</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class=page-wrapper data-wc-page-id=84c4c8059e720eb7f1c31016e7b9f4f8><script src=/js/wowchemy-init.min.ec9d49ca50e4b80bdb08f0417a28ed84.js></script><aside class=search-modal id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Keresés</h1></div><div class="col-6 col-search-close"><a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Keresés... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Keresés...></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><div class="page-header header--fixed"><header><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container-xl><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/>Ferenci Tamás honlapja</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar-content aria-expanded=false aria-label=Navigáció>
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/>Ferenci Tamás honlapja</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/#about><span>Rólam</span></a></li><li class=nav-item><a class=nav-link href=/#oktatas><span>Oktatás</span></a></li><li class=nav-item><a class=nav-link href=/#projektek><span>Projektjeim</span></a></li><li class=nav-item><a class=nav-link href=/#esszek><span>Esszéim</span></a></li><li class=nav-item><a class=nav-link href=/#publications><span>Cikkek</span></a></li><li class=nav-item><a class=nav-link href=/#contact><span>Kapcsolat</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Keresés><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences"><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav></header></div><div class=page-body><div class=pub><div class="article-container pt-3"><h1>Szívinfarktust túlélt betegek terápiahűsége a másodlagos megelőzés szempontjából fontos gyógyszeres kezelésekhez</h1><div class=article-metadata><div><span>András Jánosi</span>, <span>P Ofner</span>, <span>Zoltán Kiss</span>, <span>L Kiss</span>, <span>Róbert Gábor Kiss</span>, <span>J Dinnyes</span>, <span>Zoltán Járai</span>, <span>Gergely György Nagy</span>, <span>Gábor Veress</span>, <span>Tamás Ferenci</span></div><span class=article-date>január, 2017</span></div><div class="btn-links mb-3"><a href=# class="btn btn-outline-primary btn-page-header js-cite-modal" data-filename=/publication/mtmt-3246377/cite.bib>Idézet</a>
<a class="btn btn-outline-primary btn-page-header" href=https://doi.org/10.1556/650.2017.30795 target=_blank rel=noopener>DOI</a>
<a class="btn btn-outline-primary btn-page-header" href=https://m2.mtmt.hu/api/publication/3246377 target=_blank rel=noopener>URL</a></div></div><div class=article-container><h3>Kivonat</h3><p class=pub-abstract>INTRODUCTION AND AIM: The aim was to study the patients&rsquo; adherence to some evidence-based medication (statins, beta blockers, platelet and RAS inhibitors) after suffering a myocardial infarction, and its impact on the outcome. METHOD: Retrospective observational cohort study was carried out from the data of the Hungarian Myocardial Infarction Registry between January 1, 2013, and December 31, 2014. 14,843 patients were alive at the end of hospital treatment, from them, those who had no myocardial infarction or death until 180 days were followed for one year. The adherence was defined as the proportion of time from the index event to the endpoint (or censoring) covered with prescription fillings. The endpoint was defined as death or reinfarction. Information on filling prescriptions for statins, platelet aggregation inhibitors, beta blockers and ARB/ACEI-inhibitors were obtained. Multivariate regression was used to model adherence and survival time. RESULTS: Good adherence (>80%) to clopidogrel, statins, beta blockers, aspirin and ARB/ACEI was found in 64.9%, 54.4%, 36.5%, 31.7% and 64.0%, respectively. Patients treated with PCI during the index hospitalization had higher adherence to all medication (all p&lt;0.01), except for beta-blocker (p = 0.484). Multivariate analysis confirmed that adherence to statins, to clopidogrel and ARB/ACEI-inhibitors was associated with 10.1% (p&lt;0.0001), 10.4% (p = 0.0002) and 15.8% (p&lt;0.0001) lower hazard of endpoint respectively for 25% points increase in adherence, controlling for age, sex, performing of PCI, 5 anamnestic data and date of index event. Adherence to aspirin and beta blockers was not significantly associated with the hazard. CONCLUSION: Higher adherence to some evidence-based medications was found to be associated with improved long term prognosis of the patients. Orv Hetil. 2017; 158(27): 1051-1057.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Típus</div><div class="col-12 col-md-9"><a href=/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publikáció</div><div class="col-12 col-md-9"><em>ORVOSI HETILAP</em></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style></div><div class=share-box><ul class=share><li><a href="mailto:?subject=Sz%C3%ADvinfarktust%20t%C3%BAl%C3%A9lt%20betegek%20ter%C3%A1piah%C5%B1s%C3%A9ge%20a%20m%C3%A1sodlagos%20megel%C5%91z%C3%A9s%20szempontj%C3%A1b%C3%B3l%20fontos%20gy%C3%B3gyszeres%20kezel%C3%A9sekhez&amp;body=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-3246377%2F" target=_blank rel=noopener class=share-btn-email aria-label=envelope><i class="fas fa-envelope"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-3246377%2F&amp;t=Sz%C3%ADvinfarktust+t%C3%BAl%C3%A9lt+betegek+ter%C3%A1piah%C5%B1s%C3%A9ge+a+m%C3%A1sodlagos+megel%C5%91z%C3%A9s+szempontj%C3%A1b%C3%B3l+fontos+gy%C3%B3gyszeres+kezel%C3%A9sekhez" target=_blank rel=noopener class=share-btn-facebook aria-label=facebook><i class="fab fa-facebook"></i></a></li><li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-3246377%2F&amp;text=Sz%C3%ADvinfarktust+t%C3%BAl%C3%A9lt+betegek+ter%C3%A1piah%C5%B1s%C3%A9ge+a+m%C3%A1sodlagos+megel%C5%91z%C3%A9s+szempontj%C3%A1b%C3%B3l+fontos+gy%C3%B3gyszeres+kezel%C3%A9sekhez" target=_blank rel=noopener class=share-btn-twitter aria-label=twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-3246377%2F&amp;title=Sz%C3%ADvinfarktust+t%C3%BAl%C3%A9lt+betegek+ter%C3%A1piah%C5%B1s%C3%A9ge+a+m%C3%A1sodlagos+megel%C5%91z%C3%A9s+szempontj%C3%A1b%C3%B3l+fontos+gy%C3%B3gyszeres+kezel%C3%A9sekhez" target=_blank rel=noopener class=share-btn-linkedin aria-label=linkedin-in><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://reddit.com/submit?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-3246377%2F&amp;title=Sz%C3%ADvinfarktust+t%C3%BAl%C3%A9lt+betegek+ter%C3%A1piah%C5%B1s%C3%A9ge+a+m%C3%A1sodlagos+megel%C5%91z%C3%A9s+szempontj%C3%A1b%C3%B3l+fontos+gy%C3%B3gyszeres+kezel%C3%A9sekhez" target=_blank rel=noopener class=share-btn-reddit aria-label=reddit-alien><i class="fab fa-reddit-alien"></i></a></li></ul></div></div></div></div><div class=page-footer><div class=container><footer class=site-footer><p class="powered-by copyright-license-text">© 2023 Ferenci Tamás. This work is licensed under <a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank>CC BY NC ND 4.0</a></p><p class="powered-by footer-license-icons"><a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank aria-label="Creative Commons"><i class="fab fa-creative-commons fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-by fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nc fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nd fa-2x" aria-hidden=true></i></a></p><p class=powered-by>Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target=_blank rel=noopener>Wowchemy</a> — the free, <a href=https://github.com/wowchemy/wowchemy-hugo-themes target=_blank rel=noopener>open source</a> website builder that empowers creators.</p></footer></div></div><script src=/js/vendor-bundle.min.d26509351aa0ff874abbee824e982e9b.js></script>
<script id=search-hit-fuse-template type=text/x-template>
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script><script src=https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin=anonymous></script>
<script id=page-data type=application/json>{"use_headroom":true}</script><script src=/js/wowchemy-headroom.db4755770454eb63685f8de785c0a172.js type=module></script>
<script src=/hu/js/wowchemy.min.4d23fe86388c1f4ad1e72b6d8a853e3c.js></script><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Idézet</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Másolat</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Letöltés</a><div id=modal-error></div></div></div></div></div><script src=/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js type=module></script>
<script type=text/javascript>var sc_project=8274576,sc_invisible=1,sc_security="b688857d"</script><script type=text/javascript src=https://www.statcounter.com/counter/counter.js async></script><noscript><div class=statcounter><a title="ingyenes
webstatisztika" href=https://www.statcounter.hu/ target=_blank><img class=statcounter src=https://c.statcounter.com/8274576/0/b688857d/1/ alt="ingyenes webstatisztika" referrerpolicy=no-referrer-when-downgrade></a></div></noscript></body></html>